These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Association of Obesity or Weight Change With Coronary Heart Disease Among Young Adults in South Korea. Choi S; Kim K; Kim SM; Lee G; Jeong SM; Park SY; Kim YY; Son JS; Yun JM; Park SM JAMA Intern Med; 2018 Aug; 178(8):1060-1068. PubMed ID: 29913019 [TBL] [Abstract][Full Text] [Related]
6. Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease. Natarajan S; Liao Y; Cao G; Lipsitz SR; McGee DL Arch Intern Med; 2003 Jul; 163(14):1735-40. PubMed ID: 12885690 [TBL] [Abstract][Full Text] [Related]
7. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians. Muhammad S; Sani MU; Okeahialam BN Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991 [TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition. Maia BS; Engelson ES; Wang J; Kotler DP Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765 [TBL] [Abstract][Full Text] [Related]
9. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S; J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006 [TBL] [Abstract][Full Text] [Related]
10. Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. Savès M; Chêne G; Ducimetière P; Leport C; Le Moal G; Amouyel P; Arveiler D; Ruidavets JB; Reynes J; Bingham A; Raffi F; Clin Infect Dis; 2003 Jul; 37(2):292-8. PubMed ID: 12856222 [TBL] [Abstract][Full Text] [Related]
11. Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. Hadigan C; Meigs JB; Wilson PW; D'Agostino RB; Davis B; Basgoz N; Sax PE; Grinspoon S Clin Infect Dis; 2003 Apr; 36(7):909-16. PubMed ID: 12652392 [TBL] [Abstract][Full Text] [Related]
12. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Brown TT; Cole SR; Li X; Kingsley LA; Palella FJ; Riddler SA; Visscher BR; Margolick JB; Dobs AS Arch Intern Med; 2005 May; 165(10):1179-84. PubMed ID: 15911733 [TBL] [Abstract][Full Text] [Related]
13. Action levels for obesity treatment in 40 to 42-y-old men and women compared with action levels for prevention of coronary heart disease. Tonstad S; Graff-Iversen S Int J Obes Relat Metab Disord; 2001 Nov; 25(11):1698-704. PubMed ID: 11753593 [TBL] [Abstract][Full Text] [Related]
14. Education and coronary heart disease risk: potential mechanisms such as literacy, perceived constraints, and depressive symptoms. Loucks EB; Gilman SE; Howe CJ; Kawachi I; Kubzansky LD; Rudd RE; Martin LT; Nandi A; Wilhelm A; Buka SL Health Educ Behav; 2015 Jun; 42(3):370-9. PubMed ID: 25431228 [TBL] [Abstract][Full Text] [Related]
15. A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon. Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL PLoS One; 2016; 11(5):e0155560. PubMed ID: 27195956 [TBL] [Abstract][Full Text] [Related]
16. Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study. Martinez E; Mocroft A; García-Viejo MA; Pérez-Cuevas JB; Blanco JL; Mallolas J; Bianchi L; Conget I; Blanch J; Phillips A; Gatell JM Lancet; 2001 Feb; 357(9256):592-8. PubMed ID: 11558485 [TBL] [Abstract][Full Text] [Related]
17. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Bergersen BM; Sandvik L; Bruun JN; Tonstad S Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):625-30. PubMed ID: 15322938 [TBL] [Abstract][Full Text] [Related]
18. Lipid-lowering efficacy and safety after switching to atazanavir-ritonavir-based highly active antiretroviral therapy in patients with human immunodeficiency virus. Nguyen ST; Eaton SA; Bain AM; Rahman AP; Payne KD; Bedimo R; Herrington JD; Maclayton DO; Rodriguez-Barradas MC; Busti AJ Pharmacotherapy; 2008 Mar; 28(3):323-30. PubMed ID: 18294112 [TBL] [Abstract][Full Text] [Related]
19. Risk of cataract surgery in HIV-infected individuals: a Danish Nationwide Population-based cohort study. Rasmussen LD; Kessel L; Molander LD; Pedersen C; Gerstoft J; Kronborg G; Obel N Clin Infect Dis; 2011 Dec; 53(11):1156-63. PubMed ID: 21998282 [TBL] [Abstract][Full Text] [Related]
20. Independent predictors of metabolic syndrome in HIV-infected patients. Alencastro PR; Fuchs SC; Wolff FH; Ikeda ML; Brandão AB; Barcellos NT AIDS Patient Care STDS; 2011 Nov; 25(11):627-34. PubMed ID: 21936688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]